IP Library Patent Application 14403475
Patent Application
App. No. 14/403,475

Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/403,475
Abstract

The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multi-cellular organisms.

Claims (11)

1 .- 155 . (canceled)

156 . A method of cleaving a nucleic acid comprising contacting a target DNA molecule having a target sequence with

a) a Cas9 protein; and

b) a single molecule DNA-targeting RNA comprising

i) a targeter-RNA that hybridizes with the target sequence, and

ii) an activator-RNA that hybridizes with the targeter-RNA to form a double-stranded RNA duplex of a protein-binding segment, wherein the activator-RNA comprises the nucleotide sequence set forth as SEQ ID NO:1347,

wherein the activator-RNA and the targeter-RNA are covalently linked to one another with intervening nucleotides,

wherein said contacting is in vitro outside of a cell,

wherein the single molecule DNA-targeting RNA forms a complex with the Cas9 protein,

whereby the single molecule DNA-targeting RNA targets the target sequence, and the Cas9 protein cleaves the target DNA molecule.

157 . The method of claim 156 , wherein said double-stranded RNA duplex has a length of from 8 base pairs (bp) to 30 bp.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE LAST NAME OF THE 4TH INVENTOR PREVIOUSLY RECORDED AT REEL: 038554 FRAME: 0746. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 23, 2016
From: DOUDNA, JENNIFER A.; JINEK, MARTIN; QI, LEI S.; DOUDNA CATE, JAMES HARRISON; LIM, WENDELL A.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 038788/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: CHYLINSKI, KRZYSZTOF
To: UNIVERSITY OF VIENNA
Reel/Frame 038554/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2016
From: DOUDNA, JENNIFER A.; JINEK, MARTIN; QI, LEI S.; CATE, JAMES HARRISON DOUDNA; LIM, WENDELL A.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 038554/0746 →